Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients
Status:
Terminated
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The study will explore escalating doses of melflufen in combination with dexamethasone in
small groups of patients to find the maximum tolerated dose of melflufen. That dose will then
be used to determine the efficacy and safety profile of melflufen in combination with
dexamethasone in a larger group of patients.